Australian media heads from ABC, SBS, Nine, and News Corp demand AI companies pay for news content used for training, citing it as a "public good." Licensing talks are underway, with Anthropic approaching ABC. The Andrew Olle lecture highlighted the need to protect journalism and ensure fair compensation.
Chinese AI-driven drug-design firms are rapidly expanding their global presence through cross-border deals, with out-licensing agreements reaching US$75 billion in the first five months of 2026, despite increasing scrutiny from Washington on Chinese biotech companies. A deal between Metis TechBio and Boulevard Bio exemplifies this trend.
Financial disclosures reveal Donald Trump's family cryptocurrency ventures generated over $1 billion in his first year back in the White House. Critics accuse him of "brazen crypto corruption" and "infinite greed," while Trump dismisses scrutiny, stating he made money before the presidency.
Financial disclosures revealed Donald Trump's family cryptocurrency ventures generated over $1bn in his first year back in the White House, prompting accusations of "brazen crypto corruption" from Democratic officials and calls for new legislation to prevent officials from profiting from the crypto industry.
Royalty Pharma, the world's largest biopharmaceutical royalty buyer, established its first Asia-Pacific base in Hong Kong. This move aims to capitalize on record Chinese biotech out-licensing deals and offers an alternative financing method amidst US investment restrictions and geopolitical uncertainties.
Former Twitter CEO Parag Agarwal launches Index, an AI platform from Parallel Web Systems, to fairly compensate content creators when AI agents consume their work. The platform uses Shapely value to determine payouts based on source contribution.
Hong Kong's eight publicly funded universities are generating record income through knowledge transfer activities including patents, licensing deals, and industry partnerships. While education exports appear logical for the land-constrained city, a tension emerges: the 'international' strategy relies heavily on mainland China postgraduate enrolments, despite the international veneer of English-delivered degrees and globally connected campuses.
